ARVO 2025
Imagine Eyes will exhibit at ARVO 2025 in Salt Lake City on May 05-08, 2025. We warmly welcome all attendees to visit us on our booth #1409 and discover a new range of possibilities for investigating retinal disease at the cellular level, and for advancing the development of retinal therapies.
Cellular and microvascular retinal assessments for clinical research and clinical trials
The rtx1 AO retinal camera reveals subclinical alterations and clinical lesions at the microscopic scale, through quick exams. It provides quantification of cone cells, RPE cells and microvascular structure. Extensively validated by 250+ published studies, rtx1 enables investigating various retinal diseases, as well as tracking natural progression and therapy effects over shorter timescales than OCT or AF imaging.
This year again, rtx1 users will present new clinical findings in AMD and IRDs, as well as a novel AI-powered cone mosaic analysis.
See the poster schedule and the abstracts here.
The rtx1 comes back to ARVO with a range of exciting new features : we will be happy to introduce its full capabilities with live demos on booth #1409.
Contact us to plan your visit !
For trial sponsors and CROs
We offer global services for a successful implementation of AO biomarkers in studies and trials, through the global clinical trial equipement network of our partner Emsere. Meet us at ARVO to discuss how to accelerate your developments of retinal therapies.
